How much does entrectinib cost per month in China?

Entrectinib (Entrectinib) is an oral anti-cancer drug that belongs to the tropomyosin receptor tyrosine kinase (TRK) TRKA, TRKB, TRKC, proto-oncogene tyrosine protein kinase ROS1 and anaplastic lymphoma kinase (ALK) inhibitors. It is mainly used to treat ROS1-positive metastatic non-small cell lung cancer and NTRK gene fusion-positive solid tumors. These mutations often appear in many types of cancer. Entrectinib achieves the purpose of treating cancer by inhibiting the activity of these mutated tyrosine kinases, thereby preventing the proliferation and spread of cancer cells.

Regarding the recommended dose of entrectinib, it is usually calculated based on body surface area in pediatric patients. The recommended dose for adult patients is 600 mg per day. These doses should be continued until disease progression or unacceptable toxicity occurs.

As for the price of entrectinib in China, according to relevant news, entrectinib has entered Class B medical insurance after being launched in China. Common specifications include100mg*30 pills and 200mg*90 pills. The price of each box may be more than 20,000 yuan. Taking 200mg*90 pills as an example, an adult patient will need about the price of one box for one month's use. However, the specific price may vary depending on the region, hospital and medical insurance policy, so patients are advised to consult their local hospital or pharmacy before purchasing.

Overall, entrectinib is a broad-spectrum anticancer drug that targets specific genetic mutations, and its recommended dose is based on the patient's body surface area. In China, entrectinib has been included in medical insurance, but the price is still high, requiring patients and hospitals to reduce the financial burden. At the same time, more innovative drugs will be released to provide more treatment options for cancer patients.